Beacon Financial Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Beacon Financial Advisory's LLY Position: Q3 2026 in Review
Beacon Financial Advisory increased its Eli Lilly (LLY) stake by 7.9% in Q3 2026, buying an estimated $64.9K and bringing the position to 754 shares worth $872K. The position accounts for 0.17% of the portfolio, ranked #162.
Beacon Financial Advisory first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. 2,534 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Beacon Financial Advisory held 754 shares of Eli Lilly worth $872K as of Q3 2026.
- Beacon Financial Advisory bought 55 Eli Lilly shares in Q3 2026, an estimated $64.9K.
- Eli Lilly made up 0.17% of Beacon Financial Advisory's portfolio in Q3 2026, its #162 holding.
- Beacon Financial Advisory first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
- 2,534 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Beacon Financial Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.